BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27831558)

  • 1. RIPK1 protects from TNF-α-mediated liver damage during hepatitis.
    Filliol A; Piquet-Pellorce C; Le Seyec J; Farooq M; Genet V; Lucas-Clerc C; Bertin J; Gough PJ; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJ; Samson M
    Cell Death Dis; 2016 Nov; 7(11):e2462. PubMed ID: 27831558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis.
    Filliol A; Piquet-Pellorce C; Raguénès-Nicol C; Dion S; Farooq M; Lucas-Clerc C; Vandenabeele P; Bertrand MJM; Le Seyec J; Samson M
    J Hepatol; 2017 Jun; 66(6):1205-1213. PubMed ID: 28088582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis.
    Farooq M; Filliol A; Simoes Eugénio M; Piquet-Pellorce C; Dion S; Raguenes-Nicol C; Jan A; Dimanche-Boitrel MT; Le Seyec J; Samson M
    Cell Death Dis; 2019 Jan; 10(1):12. PubMed ID: 30622241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1 protects hepatocytes from death in Fas-induced hepatitis.
    Filliol A; Farooq M; Piquet-Pellorce C; Genet V; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJM; Samson M; Le Seyec J
    Sci Rep; 2017 Aug; 7(1):9205. PubMed ID: 28835677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl
    Hameed H; Farooq M; Vuillier C; Piquet-Pellorce C; Hamon A; Dimanche-Boitrel MT; Samson M; Le Seyec J
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.
    Schneider AT; Gautheron J; Feoktistova M; Roderburg C; Loosen SH; Roy S; Benz F; Schemmer P; Büchler MW; Nachbur U; Neumann UP; Tolba R; Luedde M; Zucman-Rossi J; Panayotova-Dimitrova D; Leverkus M; Preisinger C; Tacke F; Trautwein C; Longerich T; Vucur M; Luedde T
    Cancer Cell; 2017 Jan; 31(1):94-109. PubMed ID: 28017612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.
    Dondelinger Y; Jouan-Lanhouet S; Divert T; Theatre E; Bertin J; Gough PJ; Giansanti P; Heck AJ; Dejardin E; Vandenabeele P; Bertrand MJ
    Mol Cell; 2015 Oct; 60(1):63-76. PubMed ID: 26344099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
    Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
    FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.
    Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P
    Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
    Dillon CP; Balachandran S
    Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
    Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
    Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis.
    Van TM; Polykratis A; Straub BK; Kondylis V; Papadopoulou N; Pasparakis M
    J Clin Invest; 2017 Jun; 127(7):2662-2677. PubMed ID: 28628031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.
    Wong J; Garcia-Carbonell R; Zelic M; Ho SB; Boland BS; Yao SJ; Desai SA; Das S; Planell N; Harris PA; Font-Burgada J; Taniguchi K; Bertin J; Salas A; Pasparakis M; Gough PJ; Kelliher M; Karin M; Guma M
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):295-312. PubMed ID: 31606566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8.
    Gentle IE; Wong WW; Evans JM; Bankovacki A; Cook WD; Khan NR; Nachbur U; Rickard J; Anderton H; Moulin M; Lluis JM; Moujalled DM; Silke J; Vaux DL
    J Biol Chem; 2011 Apr; 286(15):13282-91. PubMed ID: 21339290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation.
    Koschel J; Nishanth G; Just S; Harit K; Kröger A; Deckert M; Naumann M; Schlüter D
    Cell Death Differ; 2021 Jul; 28(7):2257-2275. PubMed ID: 33712742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injury.
    Zhuang Y; Xu HC; Shinde PV; Warfsmann J; Vasilevska J; Sundaram B; Behnke K; Huang J; Hoell JI; Borkhardt A; Pfeffer K; Taha MS; Herebian D; Mayatepek E; Brenner D; Ahmadian MR; Keitel V; Wieczorek D; Häussinger D; Pandyra AA; Lang KS; Lang PA
    Gut; 2020 Jan; 69(1):133-145. PubMed ID: 31409605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
    Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.